These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16549905)

  • 1. Effect of repeated oral administrations of the oral adsorbent AST-120 on serum creatinine and other markers of renal function. A randomized controlled study in patients with chronic kidney disease.
    Marier JF; Lee J; Kambhampati SR; Galitz L; Vargas R; Moberly J; Salazar DE
    Am J Nephrol; 2006; 26(2):136-41. PubMed ID: 16549905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD.
    Schulman G; Agarwal R; Acharya M; Berl T; Blumenthal S; Kopyt N
    Am J Kidney Dis; 2006 Apr; 47(4):565-77. PubMed ID: 16564934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.
    Akizawa T; Asano Y; Morita S; Wakita T; Onishi Y; Fukuhara S; Gejyo F; Matsuo S; Yorioka N; Kurokawa K;
    Am J Kidney Dis; 2009 Sep; 54(3):459-67. PubMed ID: 19615804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
    Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
    Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
    Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A
    J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study.
    Owada A; Nakao M; Koike J; Ujiie K; Tomita K; Shiigai T
    Kidney Int Suppl; 1997 Dec; 63():S188-90. PubMed ID: 9407455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF.
    Sanaka T; Fujimoto K; Niwayama J; Nishimura H; Naito T; Higuchi C; Akizawa T; Koide K; Koshikawa S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S35-7. PubMed ID: 12612949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress.
    Fujii H; Nishijima F; Goto S; Sugano M; Yamato H; Kitazawa R; Kitazawa S; Fukagawa M
    Nephrol Dial Transplant; 2009 Jul; 24(7):2089-95. PubMed ID: 19188341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function.
    Shoji T; Wada A; Inoue K; Hayashi D; Tomida K; Furumatsu Y; Kaneko T; Okada N; Fukuhara Y; Imai E; Tsubakihara Y
    Nephron Clin Pract; 2007; 105(3):c99-107. PubMed ID: 17179734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease.
    Takahashi T; Reed SD; Schulman KA
    Nephrology (Carlton); 2008 Oct; 13(5):419-27. PubMed ID: 18518936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ADSORBENT AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Shimada N; Ebihara I; Koide H
    Kidney Blood Press Res; 2004; 27(2):121-6. PubMed ID: 15051932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
    Moist L; Sontrop JM; Gallo K; Mainra R; Cutler M; Freeman D; House AA
    Am J Kidney Dis; 2010 Oct; 56(4):643-50. PubMed ID: 20541301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Suzuki T; Ueda Y; Yamagishi S
    Metabolism; 2011 Feb; 60(2):260-4. PubMed ID: 20189611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level].
    Nakayama M; Tanno Y; Otsuka Y; Takahashi H; Ikeda M; Katoh N; Yokoyama K; Yamamoto H; Tokutome G; Hosoya T
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):530-6. PubMed ID: 12476589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases.
    Ueda H; Shibahara N; Takagi S; Inoue T; Katsuoka Y
    Ther Apher Dial; 2007 Jun; 11(3):189-95. PubMed ID: 17498000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease.
    Taki K; Niwa T
    J Ren Nutr; 2007 Jan; 17(1):48-52. PubMed ID: 17198932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent effect of an oral adsorbent, AST-120, in patients with early chronic renal failure.
    Yorioka N; Ito T; Masaki T; Ogata S; Asakimori Y; Tanji C; Kyuden Y; Komiya Y; Kumagai J; Taniguchi Y; Kohno N
    J Int Med Res; 2002; 30(5):467-75. PubMed ID: 12449515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AST-120 treatment in pre-dialysis period affects the prognosis in patients on hemodialysis.
    Ueda H; Shibahara N; Takagi S; Inoue T; Katsuoka Y
    Ren Fail; 2008; 30(9):856-60. PubMed ID: 18925523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.